Patient No. Gender Age [y] MCV [fl] ASAT [U/l] ALAT [U/l] GGT [U/l] CDT [%] Baclofen [mg/d]
      T0 T2 T0 T2 T0 T2 T0 T2 T0 T2  
1 m 35 94.0 92.0 11.0 17.0 12.0 11.0 81.0 11.0 1.8 1.5 105.00
2 f 58 94.0 90.0 17.0 18.0 18.0 22.0 46.0 6.0 2.5 1.6 75.00
3 f 34 - - 17.0 21.0 21.0 19.0 17.0 17.0 1.8 1.7 75.00
4 f 44 88.0 84.0 15.0 16.0 20.0 17.0 24.0 27.0 1.5 1.7 100.00
5 f 66 86.0 84.0 57.0 16.0 - 18.0 - 18.0 - 1.8 30.00
6 m 50 - 92.0 71.0 19.0 98.0 18.0 109.0 22.0 - 2.4 125.00
7 m 42 95.0 95.0 27.0 36.0 36.0 36.0 67.0 51.0 4.7 7.6 200.00
8 m 40 89.0 90.0 25.0 29.0 21.0 26.0 60.0 53.0 - 2.8 125.00
9 m 38 102.0 103.0 21.0 30.0 44.0 49.0 185.0 274.0 2.1 1.7 200.00
10 m 46 - - 19.0 23.0 29.0 64.0 18.0 50.0 1.7 2.1 125.00
11 f 46 99.0 96.0 27.0 33.0 24.0 28.0 23.0 11.0 9.4 2.7 60.00
12 m 32 91.0 91.0 32.0 37.0 78.0 58.0 72.0 73.0 1.8 1.5 85.00
13 m 38 100.0 94.0 29.0 26.0 47.0 45.0 160.0 111.0 - 2.2 100.00
14 m 30 99.0 91.0 16.0 33.0 17.0 18.0 - 16.0 1.8 - 75.00
15 m 38 - - 92.0 65.0 56.0 52.0 370.0 76.0 2.2 1.8 225.00
                           
M -  42.40 94.27 91.83* 31.73 27.93 37.21 32.06 94.76 54.40 2.84 2.36 115.66
SD - 6.66 5.33 5.11 23.26 12.64 25.31 17.21 98.11 67.81 2.34 1.56 55.19
Table 1: Blood testing results. T0: beginning of the observation; T2: end of the observation; -: missing value; *p<0.01
Goto home»